XYLT2 and infection: Our findings have potential therapeutic applications, insofar as deployment of conjugation systems for translocation of SOS inhibitors such as PsiB and SSB in infection settings might pose an effective block against the emergence of SOS-induced recombination or mutagenesis as drivers of antibiotic resistance.